HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center

Table 2 Comparison between two treating groups

	Before		p value	2 weeks		p value
	GPBSCs	control	p value	GPBSCs	control	p value
WBC	1.36 [0.2, 2.4]	1.8 [0.5, 7.4]	0.134	2.68 [0.17, 15.38]	3.95 [0.2, 12]	0.696
HGB	81.5 ± 17.701	94.63 ± 27.132	0.092	82.75 ± 18.614	97.19 ± 17.608	0.032
PLT	49.5 [12, 340]	45 [3, 499]	0.893	47 [3, 313]	88 [26, 451]	0.102
TG	2.59 [0.6, 12.78]	2.05 [1.39, 5.29]	0.929	1.89 [1.02, 8.86]	1.63 [0.74, 4.11]	0.093
Fbg	1.04 [0.84, 2.91]	1.045 [0.3, 2.12]	0.252	2.16 [0.77, 4.24]	1.065 [0.53, 2.74]	0.003
Ferritin	3843.1 [28, 24,174]	3207 [118, 455,000]	0.909	3352.5 [255, 40,699]	1433 [16, 7549]	0.068
AST	52.5 [13.3, 229.9]	65 [26, 766]	0.150	35.7 [12.8, 181]	28 [8, 680.2]	0.261
ALT	58 [14, 252]	76 [10, 310]	0.425	59 [6, 502]	34.5 [4, 227]	0.123
T-bil	18.725 [8.01, 85.66]	50.925 [7.48, 289.66]	0.088	33.51 [9.36, 169.14]	17.34 [1.84, 192.69]	0.551
EBV-DNA	1.1 × 10⁵ [< 5.0 × 10², 3.0 × 10⁶]	5.7 × 10⁵ [< 5.0 × 10², 5.2 × 10⁷]	0.304	5.0 × 10³ [< 5.0 × 10², 5.7 × 10⁵]	6.6 × 10⁴ [< 5.0 × 10², 9.0 × 10⁷]	0.011
ECOG	2.78	2.63	0.606	2.56	2.42	0.645

ISSN: 1757-6512